GT Biopharma
Price & Volume
Stats
See more52W Range | $1.72-$10.65 |
Market Cap | $5.7M |
Shares Short | 50,641 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$6.94 |
News
See moreYahoo Finance • 2 months ago
GT Biopharma Announces Exercise of Warrants
Yahoo Finance • last year
GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
Yahoo Finance • last year
GT Biopharma Reports Third Quarter 2023 Financial Results
Yahoo Finance • 2 years ago
GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
About
CEO | Mr. Michael Martin Breen L.L.B. |
CFO | Mr. Alan Louis Urban CPA |
Address | 315 Montgomery Street, San Francisco, CA, United States, 94104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |
